SOLV Revenue third quarter 2026 Y/Y Growth Comment
Solventum Corporation reported decrease in Revenue in the third quarter 2026 by -7.01% to $ 1,949.00 millions, from the same quarter in 2025. The decrease in the third quarter 2026 Solventum Corporation's Revenue compares unfavorably to the Company's average Revenue growth of 0.55%.
Looking into third quarter 2026 results within Medical Equipment & Supplies industry 127 other companies have achieved higher Revenue growth. While Solventum Corporation' s Revenue decline of -7.01% ranks overall at the positon no. 2576 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Solventum's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
10.06 %
0.79 %
-4.68 %
(Jun 30 2026)
SOLV's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Solventum Corporation disclosed drop in Revenue from the second quarter by -11.77% to $ 1,949.00 millions, from $ 2,209.00 millions achived in the previous reporting period.
But that's not important problem, as Solventum's Revenue generally seem to plunge in this quarter.
Within Medical Equipment & Supplies industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Solventum's Revenue growth quarter on quarter, overall rank is 827.
In the III. Quarter 2026 Solventum Corporation disclosed drop in Revenue from the second quarter by -11.77% to $ 1,949.00 millions, from $ 2,209.00 millions achived in the previous reporting period.
But that's not important problem, as Solventum's Revenue generally seem to plunge in this quarter.
Within Medical Equipment & Supplies industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Solventum's Revenue growth quarter on quarter, overall rank is 827.
Solventum's cumulative 12 months Revenue continue to decrease, but on the faster rate at -0.93% year on year, at Jun 30 2026 compare to the -0.55% decrease at Mar 31 2026. If the Solventum's fiscal year would end at Jun 30 2026, annual Revenue would be $8,310 millions.
In the Healthcare sector 344 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2307 to 2397.
Solventum's cumulative 12 months Revenue continue to decrease, but on the faster rate at -0.93% year on year, at Jun 30 2026 compare to the -0.55% decrease at Mar 31 2026. If the Solventum's fiscal year would end at Jun 30 2026, annual Revenue would be $8,310 millions.
In the Healthcare sector 344 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2307 to 2397.
About Solventum Revenue Growth Rates (SOLV), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
